Core Insights - Extendicare Inc. reported strong financial results for Q2 2025, with significant growth in revenue and adjusted EBITDA, driven by strategic acquisitions and increased demand for services [3][8][15]. Financial Performance - Revenue for Q2 2025 increased by $35.0 million to $383.4 million, representing an 11.4% growth when excluding out-of-period LTC funding from Q2 2024 [15][29]. - Adjusted EBITDA rose by $5.3 million or 15.4% to $39.8 million, reflecting growth in home health care and long-term care segments [8][15]. - Net earnings increased by $6.0 million to $31.9 million, supported by higher adjusted EBITDA and other income [15][30]. Strategic Acquisitions - The company completed the acquisition of Closing the Gap for approximately $75.1 million, expected to add 1.1 million service hours to the home health care segment [3][10]. - The acquisition of nine LTC homes from Revera for $41.3 million was finalized, enhancing the company's long-term care portfolio [6][15]. - The sale of three LTC projects to Axium JV generated net cash proceeds of $56.3 million, resulting in a gain of $11.1 million [4][15]. Operational Highlights - Home health care average daily volume (ADV) increased by 10.9% to 33,310 in Q2 2025 [8][23]. - Long-term care average occupancy rose to 98.3%, up 50 basis points from the previous year [19][20]. - The number of third-party and joint venture beds serviced by SGP reached approximately 149,300, a 5.9% increase from the prior year [24]. Financial Position - As of June 30, 2025, Extendicare had cash and cash equivalents of $72.6 million, with access to an additional $152.2 million under its revolving facility [26]. - The company increased its senior secured credit facility to $375.0 million, enhancing liquidity for future growth [3][8]. Dividend Declaration - The Board of Directors declared a cash dividend of $0.042 per share for August 2025, payable on September 15, 2025 [31].

Core Insights - Extendicare Inc. reported strong financial results for Q2 2025, with significant growth in revenue and adjusted EBITDA, driven by strategic acquisitions and increased demand for services [3][8][14]. Financial Performance - Revenue for Q2 2025 increased by $35.0 million to $383.4 million, representing an 11.4% growth when excluding out-of-period funding from Q2 2024 [14]. - Adjusted EBITDA rose by $5.3 million or 15.4% to $39.8 million, reflecting growth in home health care and improvements in long-term care [8][14]. - Net earnings increased by $6.0 million to $31.9 million, supported by higher adjusted EBITDA and other income [14][21]. Acquisitions and Transactions - The company completed the acquisition of Closing the Gap for approximately $75.1 million, expected to add 1.1 million service hours to the home health care segment [3][9]. - Extendicare acquired nine long-term care homes from Revera for approximately $41.3 million, enhancing its portfolio [6][14]. - The sale of three long-term care projects to Axium JV generated net cash proceeds of $56.3 million, resulting in a gain of $11.1 million [4][14]. Operational Highlights - Home health care average daily volume (ADV) increased to 33,310, a 10.9% rise from Q2 2024 [8][22]. - Long-term care average occupancy improved to 98.3%, up 50 basis points from the previous year [17]. - The number of third-party and joint venture beds serviced by SGP reached approximately 149,300, a 5.9% increase from the prior year [23]. Strategic Initiatives - The Ontario government announced a new capital funding policy for long-term care homes, providing greater funding flexibility for redevelopment projects [5]. - Extendicare is advancing 18 redevelopment projects to align with the new funding program [5]. Financial Position - As of June 30, 2025, Extendicare had cash and cash equivalents of $72.6 million, with access to an additional $152.2 million under its revolving facility [25]. - The company increased its senior secured credit facility to $375.0 million, enhancing its liquidity position [3][8]. Dividend Declaration - The Board of Directors declared a cash dividend of $0.042 per share for August 2025, payable on September 15, 2025 [30].